Steven Sandor - Jul 6, 2022 Form 3 Insider Report for BIOLASE, INC (BIOL)

Role
Chief Operating Officer
Signature
/s/ Michael C. Carroll, attorney-in-fact for Steven Sandor
Stock symbol
BIOL
Transactions as of
Jul 6, 2022
Transactions value $
$0
Form type
3
Date filed
7/14/2022, 06:13 PM
Next filing
Aug 12, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BIOL Common Stock 2.36K Jul 6, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BIOL Restricted Stock Unit Jul 6, 2022 Common Stock 200 Direct F1, F2
holding BIOL Restricted Stock Unit Jul 6, 2022 Common Stock 1.8K Direct F2, F3
holding BIOL Restricted Stock Unit Jul 6, 2022 Common Stock 450 Direct F2, F4
holding BIOL Restricted Stock Unit Jul 6, 2022 Common Stock 8.54K Direct F2, F5
holding BIOL Stock Option (right to buy) Jul 6, 2022 Common Stock 800 $52.75 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock unit award vests as to 200 shares on April 8, 2023, subject to the Reporting Person's continued service with the Company.
F2 At the option of the Company, each restricted stock unit represents the right to receive, at settlement, one share of common stock, or its cash equivalent.
F3 The restricted stock unit award vests as to 900 shares on each of August 10, 2022 and August 10, 2023, subject to the Reporting Person's continued service with the Company.
F4 The restricted stock unit award vests as to 450 shares on August 5, 2022, subject to the Reporting Person's continued service with the Company.
F5 The restricted stock unit award vests in accordance with performance criteria established by the Compensation Committee of the Company, subject to the Reporting Person's continued service with the Company.
F6 The stock option vests immediately as to 201 shares, and the remainder vests ratably over a 36-month period, commencing on May 8, 2020, subject to the Reporting Person's continued service with the Company.